Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Jaehde

Showing results (31-40 of 158) with videos related to

Pageof 16
Sort By:
Therapeutische Umschau. Revue Therapeutique|May 29, 2014
[Medication Reconciliation-theory and practice]Katharina Franzen, Rebekka Lenssen, Ulrich Jaehde, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 14, 2015
EditorialUlrich Jaehde, Gerd Bendas, Daniel Sehrt, et al.
Medizinische Monatsschrift Fur Pharmazeuten|June 29, 2018
Working together to enhance medication safety: working group ‚medication safety‘ of the Aktionsbündnis Patientensicherheit e.VRebekka Lenssen, Ulrich Jaehde, Ronja Woltersdorf, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
Are low molecular weight heparins able to sensitize chemoresistant tumor cells?Daniel P Stölting, Ulrich Jaehde, Michael Wiese, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2007
Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunctionMartina Baur, Anne Drescher, Margit Gneist, et al.
Medizinische Monatsschrift Fur Pharmazeuten|August 28, 2013
[Pharmaceutical care of the geriatric patient in the hospital]Katarina Kniggendorf, Katharina Klima, Linda Krolop, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 24, 2012
Determination of soluble vascular endothelial growth factor receptor 3 (sVEGFR-3) in plasma as pharmacodynamic biomarkerFriederike Kanefendt, Andreas Lindauer, Klaus Mross, et al.
Bioconjugate Chemistry|November 18, 2004
Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugsAndré Warnecke, Iduna Fichtner, Dirk Garmann, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 14, 2022
Current status and future outlooks on therapeutic drug monitoring of fluorouracilEduard Schmulenson, Nigina Zimmermann, Gerd Mikus, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 3, 2020
[Quality indicators for medication reviews in community pharmacies]Isabel Waltering, Sophie Scheppe, Verena Kurth, et al.
Pageof 16

Showing results (31-40 of 158) with videos related to

Sort By:
Pageof 16
Therapeutische Umschau. Revue Therapeutique|May 29, 2014
[Medication Reconciliation-theory and practice]Katharina Franzen, Rebekka Lenssen, Ulrich Jaehde, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 14, 2015
EditorialUlrich Jaehde, Gerd Bendas, Daniel Sehrt, et al.
Medizinische Monatsschrift Fur Pharmazeuten|June 29, 2018
Working together to enhance medication safety: working group ‚medication safety‘ of the Aktionsbündnis Patientensicherheit e.VRebekka Lenssen, Ulrich Jaehde, Ronja Woltersdorf, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
Are low molecular weight heparins able to sensitize chemoresistant tumor cells?Daniel P Stölting, Ulrich Jaehde, Michael Wiese, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2007
Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunctionMartina Baur, Anne Drescher, Margit Gneist, et al.
Medizinische Monatsschrift Fur Pharmazeuten|August 28, 2013
[Pharmaceutical care of the geriatric patient in the hospital]Katarina Kniggendorf, Katharina Klima, Linda Krolop, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 24, 2012
Determination of soluble vascular endothelial growth factor receptor 3 (sVEGFR-3) in plasma as pharmacodynamic biomarkerFriederike Kanefendt, Andreas Lindauer, Klaus Mross, et al.
Bioconjugate Chemistry|November 18, 2004
Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugsAndré Warnecke, Iduna Fichtner, Dirk Garmann, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 14, 2022
Current status and future outlooks on therapeutic drug monitoring of fluorouracilEduard Schmulenson, Nigina Zimmermann, Gerd Mikus, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|June 3, 2020
[Quality indicators for medication reviews in community pharmacies]Isabel Waltering, Sophie Scheppe, Verena Kurth, et al.
Pageof 16